The Alzheimer Society Research Portal connects researchers with Canadians looking to participate in research studies. On this website, find active studies that you can participate in to help advance research on dementia.
McMaster University is conducting a study on the effects of brain stimulation in individuals aged 50 and older with dementia or memory loss. The research focuses on using repetitive transcranial magnetic stimulation (rTMS), a noninvasive technique that delivers magnetic pulses to the brain, to enhance cognitive function and balance. The goal is to extend the positive effects of brain stimulation in improving cognition and balance in individuals with dementia.
1.) Diagnosed with Dementia and/or memory loss by a clinician
2.) Exhibit adequate oral communication skills and cognitive function
3.) Walk or stand with or without personnel or assistive devices
4.) Individuals must be greater than or equal to 50 years of age
Compass-ND is a research study designed to assess individuals with different sorts of cognitive and movement changes seen in older adults. We will look at the usefulness of imaging studies, clinical assessments and biomarker tests, together with measurements of memory, thinking and daily functioning, for distinguishing these changes from each other and from healthy aging.
- are between the ages 60-90
- have up to grade 12 education
- have an individual (spouse, friend, or relative), called a “study partner,” who is willing to:
- Accompany you to the study visits
- Communicate to the study staff of changes in your health status over the period of this study
This study aims to evaluate how older adults feel about doing a set of tasks that ask them to estimate the duration of various events and ask them to recall past memories or imagine future scenarios. This includes gathering information about the level of difficulty of the tasks and how manageable the duration of the study was. The data from this study will help design a research protocol for future research aimed at evaluating differences in time perception along the continuum of dementia. Findings may be published in a research journal or presented at research conferences.
You are eligible if you are: - at least 55 years of age - fluent in English - reside in Canada - haven’t been diagnosed with dementia - have normal or adjusted-normal vision and hearing - haven’t been diagnosed with a neurological disorder (e.g. Parkinson’s disease, brain tumour) - don't have a recent history of a medical condition that may affect your memory, thinking, or alertness (e.g. sleep apnea, hypertension) - don't have a recent history of a stroke - haven’t been diagnosed with a serious mental illness (e.g., schizophrenia, mania) - are not taking medication that may affect your memory, thinking, or alertness - don’t have a history of alcohol or drug abuse that affected your activities of daily life and/or required treatment
This study explores how adult day programs affect the lives of people living with dementia and their caregivers across several Canadian regions. Over time, we gather information about health, well-being, daily experiences, and quality of life of people living with dementia who attend day program and their caregivers. We also aim to learn about day programs themselves, such as their activities, staffing, challenges, and successes. By combining surveys, interviews, and focus groups, our program of research aims to understand what makes day programs helpful, where challenges exist, and how day program can better support families, and people who use them.
You are eligible to participate if you:
• Are an older adult living with dementia who attends or does not attend a day program
• You are a family/friend caregiver of someone living with dementia who attends or does not attend a day program
• Live in one of the participating regions (Ontario, Winnipeg MB, Calgary AB, or Interior BC)
• Are able to take part in a conversation or complete surveys, with support if needed
Hearing loss is the third most common chronic health condition among people 65 and older and increases the risk of social isolation, depression, communication difficulties and dementia. Dementia risk may be reduced through hearing rehabilitation, and it is critical to develop tools for identifying hearing loss and its impact on communication. The Hearing and Functioning in Everyday Life Questionnaire (HFEQ) is a measure to identify hearing loss and everyday life functioning, not yet been evaluated for people with combined hearing loss and cognitive impairment. To bridge this gap, the aim is to evaluate the HFEQ for this group. The study has a cross-sectional observational study design. Adults over 60 years, with hearing loss and with and without cognitive impairment will be recruited. Data collection will include a cognitive and hearing assessment, assessment of conversation effectiveness and efficiency, hearing and general health history and five questionnaires (HFEQ, the Life-Space questionnaire, the Social Functioning in Dementia scale, and the PROMIS anxiety and depression scales).
• Are 60 years or older
• Have hearing loss
• Experience cognitive complaints (subjective memory complaints, mild cognitive impairment, or dementia) or,
• Experience no changes in cognitive function
This randomized controlled study evaluates the efficacy of a hippocampus-targeted, computerized spatial memory intervention in older adults with Mild Cognitive Impairment (MCI). Participants (≥55 years) will be randomized to either (a) a spatial memory intervention program or (b) an active placebo. Primary outcomes are changes in memory and cognition from baseline to post-training and 6-month follow-up, assessed with standardized neuropsychological measures and validated spatial memory tasks. Secondary outcomes include everyday functioning, quality of life, perceived stress, and related psychosocial indices.
A neuroimaging sub-study acquires structural MRI and task-based fMRI to quantify hippocampal morphometry and functional recruitment; we hypothesize training-related improvements will correlate with hippocampal structural/functional change. Exploratory biomarkers (lipids, glucose/insulin for HOMA-IR, cortisol) and polygenic risk scores for dementia are obtained to control inter-individual variability and potential moderators/mediators of training response. The central hypothesis is that sustained, strategy-level engagement of hippocampus-dependent spatial memory will improve cognitive performance in MCI and yield convergent MRI biomarker signatures, supporting experience-dependent plasticity and informing scalable, non-pharmacologic interventions for delaying cognitive decline.
- Aged 55 years and above
- Have English or French as a primary language
- Received a diagnosis of Mild Cognitive Impairment (MCI)
This study will assess if an in-vehicle Driving Monitoring System can identify differences in driving behaviours between older adults who are cognitively healthy, those with mild cognitive impairment, and those with mild dementia.
Participants must:
• Be 65 years or older.
• Be cognitively healthy or have mild cognitive impairment or mild dementia.
• Have a valid General class driver’s license and still driving.
• Be fluent in English.
• Own an insured vehicle of 1998 or newer model year.
• Drive to at least 2 different locations per week.
Many older adults start to experience poorer sleep quality as they age, which can be associated with worse memory and cognition. Previous studies have shown that sleep can be improved when quiet sounds are presented at the right times during slow-wave sleep. We are interested in whether we can improve sleep and associated memory and cognitive function using these sounds in older adults. Information gathered from this study will be used to inform whether quiet sounds presented during slow-wave sleep can improve sleep, memory, and cognitive function.
Are 60 and older with and without mild cognitive impairment (MCI) You must be able to read, speak, or understand English.
If you do not have:
1) major psychiatric or neurological disorders
2) moderate to severe depressive or anxiety symptoms
(3) sleep disorders
(4) serious medical illness
(5) known stroke or transient ischemic attack
(6) alcohol or substance abuse
(7) a history of seizures
(8) chronic use of psychoactive or hypnotic medications, or use of any medication that alters sleep
(9) significant hearing loss or hearing aid use
(10) untreated moderate or severe sleep apnea on a home sleep apnea test.
Participants with well-controlled sleep apnea will be eligible to participate provided they are able to use their CPAP machine or other treatment device throughout the study
This study aims to evaluate the acceptance and usability of the GuardIO Family Care app, a mobile application designed to support community safety for individuals living with dementia or mild cognitive impairment and their care partners. The study also aims to analyze mobility patterns collected from the app to explore how mobility data can contribute to the early detection of cognitive impairment. The findings will help improve app design, inform care strategies, and support early intervention efforts for individuals living with dementia or MCI.
You are eligible to participate if you:
Are 18 years of age or older
Are living with mild cognitive impairment (MCI) or dementia, or are a care partner of someone with MCI or dementia
Are able to use a smartphone or tablet with the GuardIO app
Are willing to participate in the study activities, including using the app, completing questionnaires, and attending an optional focus group
Can understand and communicate in English (or another supported language, if applicable)
Follow us: